ストックスクリーナーアプリを入手
8.56
3.38%
0.28
前日終値:
$8.28
開ける：
$8.36
24時間の取引高:
261.27K
Relative Volume:
0.46
時価総額：
$527.03M
収益：
$198.53M
当期純損益:
$-63.68M
株価収益率:
-11.73
EPS:
-0.73
ネットキャッシュフロー:
$-41.50M
1週間 パフォーマンス:
+7.27%
1か月 パフォーマンス:
+82.52%
6か月 パフォーマンス:
+65.89%
1年 パフォーマンス:
-3.06%
1日の値動き範囲:
$8.36
$8.60
1週間の範囲:
$7.735
$8.75
52週間の値動き範囲:
$3.92
$15.98
Treace Medical Concepts Inc Stock (TMCI) Company Profile
名前
Treace Medical Concepts Inc
セクター
電話
(904) 373-5940
住所
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
8.56 | 527.03M | 198.53M | -63.68M | -41.50M | -0.73 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-16 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-08 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-05-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-08 | ダウングレード | Truist | Buy → Hold |
| 2023-09-29 | 開始されました | UBS | Buy |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2023-04-11 | 開始されました | Stephens | Equal-Weight |
| 2022-05-12 | 開始されました | BTIG Research | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 開始されました | JP Morgan | Overweight |
| 2021-05-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 開始されました | SVB Leerink | Outperform |
| 2021-05-18 | 開始されました | Stifel | Buy |
すべてを表示
Treace Medical Concepts Inc (TMCI) 最新ニュース
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times
Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com
Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks
Morgan Stanley's Strategic Reduction in Treace Medical Concepts Inc. - GuruFocus.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue - Investing.com India
U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn
Treace Medical (TMCI) Experiences Stock Boost After Reporting Strong Results - Stocks Telegraph
Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Treace Medical Concepts: Q3 Earnings Snapshot - San Francisco Chronicle
Treace Medical Concepts Reports Third Quarter 2024 Financial Results - The Manila Times
Vanguard Group Inc's Strategic Reduction in Treace Medical Conce - GuruFocus.com
Treace Announces Participation in the UBS Global Healthcare Conference - The Manila Times
Earnings Preview For Treace Medical Concepts - Benzinga
Treace Comments on CMS' 2025 Final Rule for Hospital Outpatient and ASC Settings - The Manila Times
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings - StockTitan
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure - The Manila Times
Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.00 Consensus PT from Brokerages - Defense World
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Reviewing Treace Medical Concepts (NASDAQ:TMCI) & BrainsWay (NASDAQ:BWAY) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Treace Medical Concepts (TMCI) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on - The Bakersfield Californian
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way? - Simply Wall St
SG Americas Securities LLC Purchases Shares of 23,591 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Bleakley Financial Group LLC Cuts Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024 - ForexTV.com
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - Benzinga
The Manufacturers Life Insurance Company Increases Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology - ForexTV.com
Truist Financial Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion ... - Post Register
Treace Medical Concepts Inc (TMCI) 財務データ
収益
当期純利益
現金流量
EPS
0.65%
大文字化:
|
ボリューム (24 時間):